Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Zeria Pharmaceutical Co Ltd (Zeria) manufactures and distributes pharmaceuticals, non-pharmaceutical products, and various health-related goods. The company offers products such as ethical products and consumer healthcare products. It’s consumer healthcare products include nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicine, cold remedies, ophthalmic solutions, anti-inflammatory and analgesics, hemorroidal remedies, dermal remedies, quasi drugs and cosmetics, among others. The company brands portfolio including Chondroitin ZS Tablets, Chondrobe, Hepalyse, Hi Jelly, Acinon, Stomase, Stomacool, New WithOne, WithOne, New Lecicarbon, Prefemin, Belfemin, Colpermin and others. Zeria is headquartered in Chuo-Ku, Tokyo, Japan.
Zeria Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Consumer Healthcare | Import and Export of Ethical Products and Consumer Healthcare Products | Acofide |
| Nutritional Health Drugs | Asacol | |
| Remedies for Gastrointestinal Diseases | Zentacort | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Zeria Pharmaceutical Co Ltd | Mitsui & Co Ltd | Otsuka Pharmaceutical Co Ltd | Mochida Pharmaceutical Co Ltd | Kowa Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Chuo-Ku | Chiyoda | Chiyoda-Ku | Shinjuku-Ku | Nagoya |
| State/Province | Tokyo | Tokyo | Tokyo | Tokyo | Aichi |
| No. of Employees | 1,746 | 56,400 | 6,070 | 1,508 | 218 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Sachiaki Ibe | Chairman; Chief Executive Officer | Executive Board | 2014 | 84 |
| Mitsuhiro Ibe | Chief Operating Officer; Director; President | Executive Board | 2014 | 54 |
| Yuuki Okazawa | Director; Managing Executive Officer | Executive Board | 2023 | 60 |
| Yoshihiro Hiraga | Managing Executive Officer | Senior Management | - | - |
| Hiroki Kato | Managing Executive Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer